Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3271551rdf:typepubmed:Citationlld:pubmed
pubmed-article:3271551lifeskim:mentionsumls-concept:C0330390lld:lifeskim
pubmed-article:3271551lifeskim:mentionsumls-concept:C0001963lld:lifeskim
pubmed-article:3271551lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:3271551lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:3271551pubmed:dateCreated1990-3-26lld:pubmed
pubmed-article:3271551pubmed:abstractTextC25H38O4.0.5CH4O, Mr = 418.6, monoclinic, P2(1), a = 19.8504 (20), b = 7.3909 (4), c = 15.7998 (18) A, beta = 93.09 (2) degrees, V = 2314.7 (8) A3, Z = 4, D chi = 1.201 Mg m-3, lambda(Cu K alpha) = 1.54184 A, mu = 0.604 mm-1, F(000) = 916, T = 295 K, R = 0.056 for 4946 unique observed reflections. The crystallographic asymmetric unit contains two steroid molecules and a molecule of methanol. All six-membered rings for both molecules have chair conformations. The D ring has a 13 beta-envelope conformation in molecule 1 and a 13 beta, 14 alpha-half-chair conformation in molecule 2. The most significant differences between the crystallographically independent steroids are in the orientation of the H atoms of the C(3) hydroxyl groups and the conformations of the propionate side chains. When the crystallographically observed molecules are subjected to energy minimization their respective hydroxyl H-atom orientations are retained, but the D rings of both molecules refine to a common 13 beta,14 alpha-half-chair conformation and a significantly different orientation of the C(17) propionate side chain is generated. A comparison with other C(17)-ester-bearing steroids suggests that the energy minimization fails to simulate fully all intramolecular interactions.lld:pubmed
pubmed-article:3271551pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3271551pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3271551pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3271551pubmed:languageenglld:pubmed
pubmed-article:3271551pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3271551pubmed:citationSubsetIMlld:pubmed
pubmed-article:3271551pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3271551pubmed:statusMEDLINElld:pubmed
pubmed-article:3271551pubmed:monthAuglld:pubmed
pubmed-article:3271551pubmed:issn0108-2701lld:pubmed
pubmed-article:3271551pubmed:authorpubmed-author:DuaxW LWLlld:pubmed
pubmed-article:3271551pubmed:authorpubmed-author:StrongP DPDlld:pubmed
pubmed-article:3271551pubmed:authorpubmed-author:GrochulskiPPlld:pubmed
pubmed-article:3271551pubmed:authorpubmed-author:WawrzakZZlld:pubmed
pubmed-article:3271551pubmed:authorpubmed-author:Ga?deckiZZlld:pubmed
pubmed-article:3271551pubmed:issnTypePrintlld:pubmed
pubmed-article:3271551pubmed:day15lld:pubmed
pubmed-article:3271551pubmed:volume44 ( Pt 8)lld:pubmed
pubmed-article:3271551pubmed:ownerNLMlld:pubmed
pubmed-article:3271551pubmed:authorsCompleteYlld:pubmed
pubmed-article:3271551pubmed:pagination1430-3lld:pubmed
pubmed-article:3271551pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3271551pubmed:meshHeadingpubmed-meshheading:3271551-...lld:pubmed
pubmed-article:3271551pubmed:meshHeadingpubmed-meshheading:3271551-...lld:pubmed
pubmed-article:3271551pubmed:meshHeadingpubmed-meshheading:3271551-...lld:pubmed
pubmed-article:3271551pubmed:year1988lld:pubmed
pubmed-article:3271551pubmed:articleTitleStructure of 1 alpha,3 alpha-trimethylene-2',5-epoxyandrostane-3 beta, 17 beta-diol 17-propionate methanol solvate (1/0.5).lld:pubmed
pubmed-article:3271551pubmed:affiliationMedical Foundation of Buffalo, Inc., New York 14203.lld:pubmed
pubmed-article:3271551pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3271551pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:3271551pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed